Preterm mortality and morbidity over 25 years
- PMID: 16790734
- PMCID: PMC2672736
- DOI: 10.1136/adc.2005.080192
Preterm mortality and morbidity over 25 years
Abstract
Changing preterm population variables have masked improvements in neonatal survival over time. Increased use of antenatal steroids, caesarean section, and surfactant may have reduced the likelihood of mortality and periventricular haemorrhage by a third and doubled that of chronic lung disease, persistent duct, and septicaemia.
Conflict of interest statement
Competing interests: none declared
References
-
- Crowley P. Prophylactic corticosteroids for preterm birth. Cochrane Database Syst Rev 20002CD000065 - PubMed
-
- Soll R F, Morley C J. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 20012CD000510 - PubMed
-
- Costeloe K, Hennessy E, Gibson A T.et al The EPICure study: outcomes to discharge from hospital for infants born at the threshold of viability. Pediatrics 2000106659–671. - PubMed
-
- Ainsworth S B, Beresford M W, Milligan D W.et al Pumactant and poractant alfa for treatment of respiratory distress syndrome in neonates born at 25–29 weeks gestation: a randomised trial. Lancet 20003551387–1392. - PubMed
-
- Milner A D. Surfactant and respiratory distress syndrome. Turk J Pediatr 19963837–43. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical